90 related articles for article (PubMed ID: 38550595)
1. Editorial: Sphingolipids in infections, diseases, and disorders.
Naz F; Arish M; Hassan I
Front Immunol; 2024; 15():1392055. PubMed ID: 38550595
[No Abstract] [Full Text] [Related]
2. Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming.
Sukocheva OA
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385066
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases.
O'Sullivan S; Dev KK
Neuropharmacology; 2017 Feb; 113(Pt B):597-607. PubMed ID: 27825807
[TBL] [Abstract][Full Text] [Related]
4. Insight into modulators of sphingosine-1-phosphate receptor and implications for cardiovascular therapeutics.
Xie YX; Yao H; Peng JF; Ni D; Liu WT; Li CQ; Yi GH
J Drug Target; 2024 Dec; 32(3):300-310. PubMed ID: 38269855
[TBL] [Abstract][Full Text] [Related]
5. The Role of Sphingolipids and Sphingosine-1-phosphate-Sphingosine-1-phosphate-receptor Signaling in Psoriasis.
Masuda-Kuroki K; Alimohammadi S; Di Nardo A
Cells; 2023 Sep; 12(19):. PubMed ID: 37830566
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-Phosphate Signaling in Cardiovascular Diseases.
Wang N; Li JY; Zeng B; Chen GL
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238688
[TBL] [Abstract][Full Text] [Related]
7. Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology.
Jamjoum R; Majumder S; Issleny B; Stiban J
Front Physiol; 2023; 14():1229108. PubMed ID: 38235387
[TBL] [Abstract][Full Text] [Related]
8. Altered sphingolipid pathway in SARS-CoV-2 infected human lung tissue.
Khan RJ; Single SL; Simmons CS; Athar M; Liu Y; Bodduluri S; Benson PV; Goliwas KF; Deshane JS
Front Immunol; 2023; 14():1216278. PubMed ID: 37868972
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids, mycobacteria and host: Unraveling the tug of war.
Mohammed SA; Saini RV; Jha AK; Hadda V; Singh AK; Prakash H
Front Immunol; 2022; 13():1003384. PubMed ID: 36189241
[No Abstract] [Full Text] [Related]
10. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives.
Bravo GÁ; Cedeño RR; Casadevall MP; Ramió-Torrentà L
Cells; 2022 Jun; 11(13):. PubMed ID: 35805142
[TBL] [Abstract][Full Text] [Related]
11. Selective Sphingosine 1-Phosphate Receptor 1 Modulation Augments Thrombolysis of Low-Dose Tissue Plasminogen Activator Following Cerebrovascular Thrombosis.
Li HD; Li R; Kong Y; Zhang W; Qi C; Wang D; Hao H; Liu Q
Front Immunol; 2022; 13():801727. PubMed ID: 35720286
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate receptors 2 and 3 reprogram resting human macrophages into M1 phenotype following mycobacteria infection.
Arish M; Naz F
Curr Res Immunol; 2022; 3():110-117. PubMed ID: 35676924
[No Abstract] [Full Text] [Related]
13. Personalized therapy: can it tame the COVID-19 monster?
Arish M; Naz F
Per Med; 2021 Sep; 18(6):583-593. PubMed ID: 34649460
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
